Ying Yang
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 8
- Oncology 38
- HER2/EGFR in Cancer Research 10
- Cancer-related Molecular Pathways 7
- Co-authors
- Terry L. Smith (11 shared papers)Hai‐Liang Zhu (16 shared papers)Gabriel N. Hortobágyi (6 shared papers)Aman U. Buzdar (4 shared papers)Shu‐Wan Kau (3 shared papers)Sharon H. Giordano (1 shared paper)Mei Kong (12 shared papers)Yu Shen (9 shared papers)
- Journals
- Cancer (10 papers)Bioorganic & Medicinal Chemistry (8 papers)Nature Communications (5 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)European Journal of Medicinal Chemistry (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ying Yang
130 papers receiving 5.0k citations
Ying Yang's Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 1.3k
- Oncology 1.7k
- Molecular Biology 2.2k
- Pulmonary and Respiratory Medicine 868
- Pathology and Forensic Medicine 432
Countries citing papers authored by Ying Yang
This map shows the geographic impact of Ying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Yang more than expected).
Fields of papers citing papers by Ying Yang
This network shows the impact of papers produced by Ying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Yang. The network helps show where Ying Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 400 | |
| 2 | 2016 | 276 | |
| 3 | 2004 | 253 | |
| 4 | 2020 | 200 | |
| 5 | 2005 | 192 | |
| 6 | One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China Hit paper breakdown → | 2022 | 149 |
| 7 | 2018 | 133 | |
| 8 | 2008 | 132 | |
| 9 | 2009 | 119 | |
| 10 | 2004 | 117 | |
| 11 | 2003 | 99 | |
| 12 | 2002 | 97 | |
| 13 | 2005 | 93 | |
| 14 | 2014 | 89 | |
| 15 | Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate. | 2002 | 85 |
| 16 | 2019 | 83 | |
| 17 | 2010 | 82 | |
| 18 | 2006 | 82 | |
| 19 | 2009 | 79 | |
| 20 | 2020 | 74 |
About Ying Yang
Ying Yang is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 136 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), HER2/EGFR in Cancer Research (10 papers), Synthesis and biological activity (10 papers), RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (8 papers), Cancer-related Molecular Pathways (7 papers), Immune cells in cancer (6 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.7k citations), Molecular Biology (2.2k citations), Pulmonary and Respiratory Medicine (868 citations) and Pathology and Forensic Medicine (432 citations). Ying Yang has collaborated with scholars based in China, United States and France. Frequent co-authors include Terry L. Smith, Hai‐Liang Zhu, Gabriel N. Hortobágyi, Aman U. Buzdar, Shu‐Wan Kau, Sharon H. Giordano, Mei Kong, Yu Shen, Lei Shi and Daren Shi. Their work appears in journals such as Cancer, Bioorganic & Medicinal Chemistry, Nature Communications, Bioorganic & Medicinal Chemistry Letters and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.